ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Donors"

  • 2018 American Transplant Congress

    Effect of Kidney Allocation System on a Solitary, Isolated, Rural Transplant Program

    K. Brown,2 S. Hill,2 L. Lipscomb,2 A. Jones,2 J. Africa.1

    1Glickman Institute, Cleveland Clinic, Cleveland, OH; 2Urology and Renal Transplant, Charleston Area Medical Center, Charleston, WV.

    The new kidney allocation system (KAS) was expected to create an impact on smaller, rural and geographically isolated centers.Methods. We examined the changes by the…
  • 2018 American Transplant Congress

    Transplantation of Restored Kidneys from Living Related Donors after Small Renal Tumor Resection: Report of 5 Cases

    Y. Ogawa,1 S. Shiroma,2 K. Kojima,2 R. Mannami,2 M. Mannami,2 N. Mitsuhata,2 M. Nishi,4 H. Afuso.3

    1Urology, Tokyo-West Tokushukai Hospital, Akishima, Tokyo, Japan; 2Urology, Uwajima Toikushukai Hospital, Uwajima, Ehime, Japan; 3Urology, Okinawa Chubu Tokushukai Hospital, Okinawa, Japan; 4Urology, Saint Martin's Hospital, Sakaide, Kagawa, Japan.

    Purpose: We launched a clinical trial registered at ClinicalTrials.gov that aimed to study the utility and safety of restored kidney transplantation between family members using…
  • 2018 American Transplant Congress

    High Kidney Donor Profile Index (KDPI) Donor Kidneys: Use Them, Don't Lose Them!

    D. Harriman, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.

    Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.

    Introduction: With the development of the Kidney Donor Profile Index (KDPI) and a new Kidney Allocation System (KAS) implemented on 12/4/14, the expanded criteria donor…
  • 2018 American Transplant Congress

    Multi-Center Examination of the Reliability and Validity of the Live Donor Assessment Tool (LDAT) as an Enhancement to the Psychosocial Evaluation of Living Donors

    D. LaPointe Rudow,1 S. Jowsey-Gregoire,2 F. Desrosiers,3 J. Trompeta,4 LDAT Study Group.1

    1RMTI, Mount Sinai Hosptial, NY, NY; 2Mayo Clinic, Rochester, MN; 3NYPH, NY, NY; 4UCSF, San Francisco, CA.

    Purpose: The LDAT is the first psychosocial assessment tool developed to standardize live donor (LD) psychosocial evaluations (PsychE). It assesses motivation, LD knowledge/expectations, support, closeness…
  • 2018 American Transplant Congress

    The THINKER Trial: Quality of Life Results at 6- and 12-Month Follow-Up among Hepatitis C-Negative Patients Who Received Kidney Transplants from Deceased Donors with Hepatitis C Infection

    V. Potluri, D. Goldberg, A. Peter, B. Emily, B. Roy, S. Deirdre, M. Levine, J. Trofe-Clark, M. Bleicher, S. Goral, A. Sicilia, S. Nazarian, R. Reddy, P. Porrett, P. Reese.

    Univ of Pennsylvania, Philadelphia, PA.

    Background: Short-term (6-month) data from the first 10 subjects in the pilot THINKER-1 trial (NCT02743897; funder: Merck) suggested that kidneys from HCV-infected donors could be…
  • 2018 American Transplant Congress

    Waiting for the Optimal Donor for MCS Patients Awaiting Heart Transplant

    J. Kobashigawa, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, E. Passano, L. Czer, J. Moriguchi, F. Arabia.

    Cedars Sinai Medical Center, Los Angeles.

    Purpose: Patients (pts) bridged with mechanical circulatory support (MCS) may require more optimal donors for best outcome compared to non-bridged transplant recipients. MCS pts have…
  • 2018 American Transplant Congress

    Temporal Trends, Predictive Factors, and Regional Differences in Discard of Increased-Risk Kidneys

    J. Lipinska, D. Clark, J. Whiting.

    Surgery, Maine Medical Center, Portland, ME.

    Purpose: Public Health Service (PHS) criteria designate certain deceased donors (DD) as entailing increased risk (IR) for disease transmission, and these constitute an expanding proportion…
  • 2018 American Transplant Congress

    Impact of Donation after Cardiac Death Allografts on Outcome Following Liver Transplantation for Fulminant Hepatic Failure: An Analysis of the UNOS Database

    S. Kumar,1 S. Lin,2 J. Schold.2

    1Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.

    Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of extended criteria donors (ECDs), including donation after cardiac death (DCD) donors. The narrow…
  • 2018 American Transplant Congress

    Human Atrial Natriuretic Peptide (hANP) in Cold Storage of Donation after Cardiac Death Livers: A New Tool for Protecting Vascular Endothelia?

    Y. Nigmet,1 K. Hata,1 Y. Okamura,1 I. Tamaki,1 T. Tsuruyama,2 H. Hirao,1 T. Kubota,1 J. Kusakabe,1 J. Yoshikawa,1 T. Goto,1 T. Tajima,1 H. Tanaka,1 S. Uemoto.1

    1Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kyoto University, Kyoto, Japan; 2Center for Anatomical, Pathological, and Forensic Medical Research, Kyoto University, Kyoto, Japan.

    Aim: Current critical shortage of donor organs has led to acceptance of donation after cardiac death (DCD) livers for transplantation. Human atrial natriuretic peptide (hANP)…
  • 2018 American Transplant Congress

    Lack of Efficacy of Eculizumab for Prevention of Delayed Graft Function (DGF) in Deceased Donor Kidney Transplant Recipients

    P. Heeger,1 E. Akalin,2 M. Baweja,1 R. Bloom,3 S. Florman,1 B. Haydel,1 D. Hricik,4 S. Kulkarni,5 A. Mehrotra,1 A. Patel,6 E. Poggio,7 L. Ratner,8 S. Schröppel,1 R. Shapiro.1

    1Mount Sinai Hosp, NY, NY; 2Montefiore Hosp, NY, NY; 3Hosp U Pa, Phila, PA; 4U Hosp Cleveland, Cleveland, OH; 5Yale U Hosp, New Haven, CT; 6St Barnabas Med Ctr, Livingston, NJ; 7Cleveland Clinic, Cleveland, OH; 8Columbia-Presbyterian Hosp, NY, NY.

    DGF portends poor short- and long-term renal function, increases cost, and may reduce graft survival. We studied the safety/efficacy of eculizumab (ECU), a C5 convertase…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 46
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences